Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Clinical trial NCT02605486 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02605486
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-11
- Primary completion
- 2026-11-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.